Older Adults and Immune Thrombocytopenia: Considerations for the Clinician
Etienne Crickx,1,2 Matthieu Mahévas,1,3,4 Marc Michel,1 Bertrand Godeau1 1Service de Médecine Interne, Centre national de référence des cytopénies auto-immunes de l’adulte, Hôpital Henri Mondor, Fédération Hospitalo-Universitaire TRUE InnovaTive theRapy for immUne disordErs, Assistance Publique Hôpi...
Main Authors: | Crickx E, Mahévas M, Michel M, Godeau B |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-01-01
|
Series: | Clinical Interventions in Aging |
Subjects: | |
Online Access: | https://www.dovepress.com/older-adults-and-immune-thrombocytopenia-considerations-for-the-clinic-peer-reviewed-fulltext-article-CIA |
Similar Items
-
Second-line and beyond: treatment options for primary persistent and chronic immune thrombocytopenia
by: Samuel Deshayes, et al.
Published: (2020-04-01) -
Pathophysiology, Diagnosis and Treatment of Immune Thrombocytopenia
by: Mihnea-Alexandru Găman, et al.
Published: (2017-03-01) -
A practical guide to the management of immune thrombocytopenia co-existing with acute coronary syndrome
by: Alaa Rahhal, et al.
Published: (2024-04-01) -
Treatment Patterns Among Adults with Primary Immune Thrombocytopenia Diagnosed in Hematology Clinics in the United States
by: McGrath LJ, et al.
Published: (2020-05-01) -
Efficacy and safety of two rituximab biosimilars for treating immune thrombocytopenia: a reference-product matched study
by: Arthur Mageau, et al.
Published: (2023-12-01)